Deborah Wenkert

2021

In 2021, Deborah Wenkert earned a total compensation of $2.4M as Former Senior Vice President and Former Chief Medical Officer at Inozyme Pharma.

Compensation breakdown

Option Awards$1,891,259
Salary$361,106
Other$109,918
Total$2,362,283

Wenkert received $1.9M in option awards, accounting for 80% of the total pay in 2021.

Wenkert also received $361.1K in salary and $109.9K in other compensation.

Rankings

In 2021, Deborah Wenkert's compensation ranked 5,387th out of 12,415 executives tracked by ExecPay. In other words, Wenkert earned more than 56.6% of executives.

ClassificationRankingPercentile
All
5,387
out of 12,415
57th
Division
Manufacturing
2,268
out of 5,501
59th
Major group
Chemicals And Allied Products
986
out of 2,371
58th
Industry group
Drugs
878
out of 2,092
58th
Industry
Pharmaceutical Preparations
629
out of 1,542
59th
Source: SEC filing on April 27, 2022.

Wenkert's colleagues

We found three more compensation records of executives who worked with Deborah Wenkert at Inozyme Pharma in 2021.

2021

Axel Bolte

Inozyme Pharma

Chief Executive Officer

2021

Henric Bjarke

Inozyme Pharma

Chief Operating Officer

2021

Steven Jungles

Inozyme Pharma

Former Senior Vice President and Chief Technical Operations Officer

News

In-depth

You may also like